Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Big Pharma Ramps up Expansion to Emerging Markets
How to Utilize FSPs for Better Outcomes
Breaking Barriers: Strategic Use of FSP Models to Expand Trials into Non-Footprint Countries
Exploring Oligonucleotide Drugs: An Overview of Pharmacokinetic & Bioanalytical Strategies
Indian Pharmaceutical Industry at a Crossroads
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Piramal Pharma Revenue Increases 12% YoY in Q1
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Almac Completes FDA Inspection at Charnwood, UK Facilities
Capra Biosciences Receives $7.5M Project Agreement
RxSource to Relocate to Larger Facility in West Deptford, NJ
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Contract Pharma Talks with Tom Handel of Kindeva Drug Delivery
Good as Gold: Douglas CDMO
Antares Vision Group Launches Supply Chain Visibility Solution
"3 Key Trends" with Stacey Treichler
Pharma Matters Podcast: Contract Pharma Talks with Tom Wilson of Pfizer CentreOne
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
Trends Impacting Clinical Trials Today
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Almac Completes FDA Inspection at Charnwood, UK Facilities
Nordic Bioproducts Receives EXCiPACT Certification for MCC Production at Lappeenranta Facility
Upperton Pharma Gains MHRA Approval at Nottingham Facility
Quality Management Systems: The Future of Quality Oversight
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
TaiMed Biologics
INCOG BioPharma Services
AMERIPHARMA
BioTechnique
CMC Pharmaceuticals
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
TaiMed Biologics
INCOG BioPharma Services
AMERIPHARMA
BioTechnique
CMC Pharmaceuticals
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Drug Discovery and Development
All
Analytical Services
Bioanalytical Services
Bioassay Development
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Breaking News
|
Drug Development
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
UCART22 is an allogenic CAR T-cell product candidate for the treatment of Acute Lymphoblastic Leukemia.
07.26.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Facilities
|
Industry News
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
$800 million investment in New Jersey supports technologically advanced manufacturing capacity and clinical development capabilities.
07.25.24
Analytical Services
|
Bioanalytical Services
|
Breaking News
|
Facilities
|
Industry News
|
Inspections
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Proven track record of consistent high quality confirmed at Pace Life Sciences’ headquarters.
07.25.24
Breaking News
|
Clinical Trials
|
CRO News
|
Information Technology
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
Aims to accelerate the development of automated text processing solutions tailored for clinical research.
07.25.24
Clinical Trials
|
Drug Development
|
Information Technology
Trends Impacting Clinical Trials Today
Insights on key challenges CROs face and outsourcing and technology trends.
Online Exclusives
Kristin Brooks, Managing Editor, Contract Pharma
07.25.24
Analytical Services
|
Breaking News
|
Collaborations & Alliances
Neuraxpharm to Utilize Veeva Quality Applications
Will drive seamless collaboration across Neuraxpharm’s network of over 100 CDMOs.
07.25.24
Fill/Finish
|
Information Technology
Embracing Automation
Enhancing quality and speed in pharma liquid filling.
Online Exclusives
Emily Newton, Contributing Writer
07.24.24
Aseptic Processing
|
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Cytotoxics and High Potency Manufacturing
|
Fill/Finish
|
Industry News
Agilent to Acquire North American CDMO BioVectra
Expands Agilent’s biopharma services for drug discovery, development, and manufacturing.
07.24.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
De Motu Cordis Expands DPI Partnership with Catalent
Announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product.
07.24.24
Analytical Services
|
Breaking News
|
Collaborations & Alliances
IDT Bolsters CRISPR Portfolio with SeQure Dx Licensing Deal
Agreement enables IDT to support cell and gene therapy developers through all phases of their CRISPR-based therapeutic programs.
07.24.24
Breaking News
|
Clinical Trials
|
Drug Development
ViroCell Signs Master Services Agreement with Prominent Cancer Center
Grants the cancer center access to ViroCell’s full range of pre-clinical and clinical viral vector services.
07.23.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Facilities
|
Industry News
|
Parenterals
Galderma Granted Manufacturing License Updates for New Biologics Capabilities
Establishes the Uppsala site as a world-class center of excellence for dermatology products.
07.23.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Touchlight, GSK Enter License Agreement
Grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA technology.
07.23.24
Analytical Services
|
Solid Dosage/Creams/Ointments
A Novel Stream Sampler for Flowing Pharmaceutical Powder Mixtures
Dr. Rodolfo Romañach and Dr. Rafael Méndez from the University of Puerto Rico, Mayagüez, present a stream sampler for real-time monitoring of powder blends.
Emil W. Ciurczak, Contributing Writer
07.22.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Univercells Technologies & UPENN Expand Gene Therapy Partnership
Will evaluate certain bioreactors for scalable gene therapy production.
07.18.24
Breaking News
|
Facilities
|
Microbiology
Scorpius Executes First cGMP Microbial Batches at San Antonio Facility
Is poised to execute additional cGMP activities throughout the remainder of the year.
07.18.24
Biosimilars
|
Breaking News
Boehringer Ingelheim, GoodRx Launch Patient Affordability Initiative
Will provide Boehringer's biosimilar to Humira at a low cash price available exclusively on GoodRx.
07.18.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
Full-Life Technologies, SK Biopharma Enter $571.5M License Agreement for FL-091
FL-091 is a small-molecule radioligand vector designed to deliver targeted radiation therapy to cancer cells by binding specifically to NTSR1.
07.17.24
Breaking News
|
Drug Development
Cardurion Raises $260M Series B Financing
Proceeds will be used to support later-stage clinical trials with the company’s two lead drug candidates.
07.16.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
SPI Pharma, Inimmune Partner to Develop & Commercialize Adjuvant Systems
Collaboration aims to provide reliable supply and open access to advanced adjuvant systems.
07.16.24
Breaking News
Piramal Pharma Revenue Increases 12% YoY in Q1
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
View Breaking News >
CURRENT ISSUE
July/August 2024
Big Pharma Ramps up Expansion to Emerging Markets
How to Utilize FSPs for Better Outcomes
View More >